Headway Capital Partners’ Christiaan de Lint says his firm, with its knack for direct secondaries, relishes ‘handling deals that other secondaries buyers don’t like’.
4 min read · 05 December 2017
The fact that Apax Partners shelved plans for its GP-led secondaries process shows that LPs desire a genuine ‘do nothing’ option.
3 min read · 20 October 2017
In this extract from The Secondaries Market, Brian Mooney and Jeremy Joersz of Greenhill Cogent examine the changes in the sector over the last 20 years, and look at the types of market participants.
5 min read · 18 July 2017
Amid the emergence of managers specialising in GP-led deals, advisors are still vital in a complex sector with inherent conflicts of interest, according to Yaron Zafir, head of secondaries at London-based advisory firm Rede Partners.
3 min read · 25 November 2016
While secondaries deals are at their core simply trades, buyers have become more specialised, and advisors too have become more selective about the areas they compete in, according to Sixpoint Partners’ Shawn Schestag.
3 min read · 23 October 2016
Recent SEC focus on fund restructuring has put pressure on GPs to make sure their limited partners get fair treatment during the process. Molly Diggins, general counsel for advisory firm Monument, who says LPs should make themselves heard and ask for greater transparency.
4 min read · 14 October 2016
Adam Howarth, co-head of private equity secondaries at Partners Group, explains how heightened anxiety in the market is impacting activity at the firm and why secondaries returns will become increasingly mixed.
5 min read · 27 September 2016
Some GP-led deals fail due to a lack of trust, and GPs should be completely transparent about any benefits they receive, according to law firm Proskauer Rose’s Howard Beber and Michael Suppappola.
4 min read · 18 August 2016
The private equity industry and insurance firms in particular can benefit from securitisation, according to Park Hill’s Larry Thuet and Pablo Caló.
4 min read · 11 July 2016
A model is emerging in the GP-led solutions market that can eliminate conflicts of interest, writes Evoco partner and co-founder Michel Galeazzi.
3 min read · 21 June 2016
